US Stock MarketDetailed Quotes

ASMB Assembly Biosciences

Watchlist

15.040
-0.090-0.59%

Close Jul 22 16:00 ET

95.44MMarket Cap-1421P/E (TTM)

Assembly Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

21.62%-18.36M

126.93%22.74M

482.50%73.65M

30.14%-13.85M

23.80%-13.63M

14.81%-23.43M

9.56%-84.46M

0.56%-19.25M

-4.98%-19.82M

17.99%-17.89M

Net income from continuing operations

52.10%-9.08M

34.23%-61.23M

51.05%-10.96M

37.70%-14.42M

30.93%-16.9M

17.93%-18.95M

28.31%-93.09M

62.83%-22.4M

-23.09%-23.15M

-3.67%-24.46M

Operating gains losses

----

--139K

----

Depreciation and amortization

-74.19%32K

-9.64%450K

-32.26%84K

-13.43%116K

5.00%126K

3.33%124K

6.87%498K

3.33%124K

12.61%134K

0.00%120K

Other non cash items

-58.01%359K

0.06%3.51M

115.91%4.41M

-71.60%514K

-83.16%-2.27M

-4.26%855K

-8.72%3.51M

127.00%2.04M

100.44%1.81M

-237.58%-1.24M

Change In working capital

-26.42%-9.15M

3,697.60%76.34M

8,440.31%80.07M

-346.70%-880K

-27.38%4.39M

-3.19%-7.24M

81.39%-2.12M

-158.68%-960K

93.07%-197K

534.70%6.05M

-Change in receivables

--0

248.19%901K

-114.24%-43K

147.30%342K

37,400.00%375K

220.74%227K

-168.01%-608K

-30.25%302K

-53.18%-723K

101.06%1K

-Change in prepaid assets

59.20%-652K

-31.02%916K

95.22%-35K

-76.54%446K

1,129.82%2.1M

-13,216.67%-1.6M

19.75%1.33M

-190.71%-732K

622.25%1.9M

-52.89%171K

-Change in payables and accrued expense

59.08%-2.25M

-41,814.29%-5.84M

-686.10%-2.6M

-13.71%-564K

-54.77%2.83M

-1.57%-5.51M

100.17%14K

-129.90%-331K

-150.15%-496K

995.85%6.26M

-Change in other current assets

--0

-29.12%577K

-66.85%240K

-1,100.00%-220K

-99.63%2K

217.58%555K

-82.64%814K

230.59%724K

-99.47%22K

1,015.25%540K

-Change in other current liabilities

49.56%-463K

-2.83%-3.77M

-14.19%-1.05M

1.89%-884K

0.54%-918K

3.06%-3.67M

0.75%-923K

1.21%-901K

-2.21%-923K

-Change in other working capital

---5.79M

--83.56M

----

Cash from discontinued investing activities

Operating cash flow

21.62%-18.36M

126.93%22.74M

482.50%73.65M

30.14%-13.85M

23.80%-13.63M

14.81%-23.43M

9.56%-84.46M

0.56%-19.25M

-4.98%-19.82M

17.99%-17.89M

Investing cash flow

Cash flow from continuing investing activities

72.72%17.27M

-176.28%-69.14M

-641.32%-89.65M

-39.93%18.88M

-187.16%-8.37M

-69.74%10M

241.84%90.64M

295.21%16.56M

56.61%31.43M

410.88%9.6M

Net PPE purchase and sale

---14K

-126.47%-231K

---47K

-33.33%-136K

---48K

--0

95.44%-102K

--0

---102K

----

Net business purchase and sale

----

--0

----

0.00%1.5M

----

Net investment purchase and sale

72.86%17.29M

-177.21%-68.91M

-694.92%-89.61M

-39.69%19.02M

-186.66%-8.32M

-69.74%10M

227.45%89.24M

251.13%15.06M

57.12%31.53M

410.88%9.6M

Cash from discontinued investing activities

Investing cash flow

72.72%17.27M

-176.28%-69.14M

-641.32%-89.65M

-39.93%18.88M

-187.16%-8.37M

-69.74%10M

241.84%90.64M

295.21%16.56M

56.61%31.43M

410.88%9.6M

Financing cash flow

Cash flow from continuing financing activities

2,150.49%13.82M

2,003.43%9.19M

-24.29%134K

4.49M

-98.84%614K

-83.89%437K

-97.13%177K

Net common stock issuance

--0

4,112.00%13.69M

2,713.23%9.14M

--0

--54K

--4.49M

-99.38%325K

-87.50%325K

--0

Proceeds from stock option exercised by employees

----

-55.36%129K

-56.25%49K

--0

----

12.02%289K

-1.75%112K

--0

----

Cash from discontinued financing activities

Financing cash flow

--0

2,150.49%13.82M

2,003.43%9.19M

--0

-24.29%134K

--4.49M

-98.84%614K

-83.89%437K

--0

-97.13%177K

Net cash flow

Beginning cash position

-62.15%19.84M

14.88%52.42M

-51.24%26.66M

-49.79%21.62M

-15.03%43.48M

14.88%52.42M

-23.24%45.63M

-22.73%54.67M

-27.65%43.06M

-34.60%51.17M

Current changes in cash

87.78%-1.09M

-579.71%-32.58M

-202.22%-6.82M

-56.65%5.03M

-169.50%-21.86M

-261.10%-8.94M

149.15%6.79M

91.03%-2.26M

3.26%11.61M

56.71%-8.11M

End cash Position

-56.88%18.75M

-62.15%19.84M

-51.24%26.66M

-49.79%21.62M

-15.03%43.48M

14.88%52.42M

-22.73%54.67M

-27.65%43.06M

Free cash flow

21.56%-18.38M

126.59%22.49M

482.13%73.58M

29.81%-13.98M

23.53%-13.68M

14.81%-23.43M

12.36%-84.57M

0.65%-19.25M

-5.52%-19.92M

17.99%-17.89M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	21.62%-18.36M	126.93%22.74M	482.50%73.65M	30.14%-13.85M	23.80%-13.63M	14.81%-23.43M	9.56%-84.46M	0.56%-19.25M	-4.98%-19.82M	17.99%-17.89M
Net income from continuing operations	52.10%-9.08M	34.23%-61.23M	51.05%-10.96M	37.70%-14.42M	30.93%-16.9M	17.93%-18.95M	28.31%-93.09M	62.83%-22.4M	-23.09%-23.15M	-3.67%-24.46M
Operating gains losses	----	--139K	----	----	----	----	----	----	----	----
Depreciation and amortization	-74.19%32K	-9.64%450K	-32.26%84K	-13.43%116K	5.00%126K	3.33%124K	6.87%498K	3.33%124K	12.61%134K	0.00%120K
Other non cash items	-58.01%359K	0.06%3.51M	115.91%4.41M	-71.60%514K	-83.16%-2.27M	-4.26%855K	-8.72%3.51M	127.00%2.04M	100.44%1.81M	-237.58%-1.24M
Change In working capital	-26.42%-9.15M	3,697.60%76.34M	8,440.31%80.07M	-346.70%-880K	-27.38%4.39M	-3.19%-7.24M	81.39%-2.12M	-158.68%-960K	93.07%-197K	534.70%6.05M
-Change in receivables	--0	248.19%901K	-114.24%-43K	147.30%342K	37,400.00%375K	220.74%227K	-168.01%-608K	-30.25%302K	-53.18%-723K	101.06%1K
-Change in prepaid assets	59.20%-652K	-31.02%916K	95.22%-35K	-76.54%446K	1,129.82%2.1M	-13,216.67%-1.6M	19.75%1.33M	-190.71%-732K	622.25%1.9M	-52.89%171K
-Change in payables and accrued expense	59.08%-2.25M	-41,814.29%-5.84M	-686.10%-2.6M	-13.71%-564K	-54.77%2.83M	-1.57%-5.51M	100.17%14K	-129.90%-331K	-150.15%-496K	995.85%6.26M
-Change in other current assets	--0	-29.12%577K	-66.85%240K	-1,100.00%-220K	-99.63%2K	217.58%555K	-82.64%814K	230.59%724K	-99.47%22K	1,015.25%540K
-Change in other current liabilities	49.56%-463K	-2.83%-3.77M	-14.19%-1.05M	1.89%-884K	0.54%-918K	0.54%-918K	3.06%-3.67M	0.75%-923K	1.21%-901K	-2.21%-923K
-Change in other working capital	---5.79M	--83.56M	----	----	----	----	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	21.62%-18.36M	126.93%22.74M	482.50%73.65M	30.14%-13.85M	23.80%-13.63M	14.81%-23.43M	9.56%-84.46M	0.56%-19.25M	-4.98%-19.82M	17.99%-17.89M
Investing cash flow
Cash flow from continuing investing activities	72.72%17.27M	-176.28%-69.14M	-641.32%-89.65M	-39.93%18.88M	-187.16%-8.37M	-69.74%10M	241.84%90.64M	295.21%16.56M	56.61%31.43M	410.88%9.6M
Net PPE purchase and sale	---14K	-126.47%-231K	---47K	-33.33%-136K	---48K	--0	95.44%-102K	--0	---102K	----
Net business purchase and sale	----	--0	----	----	----	----	0.00%1.5M	----	----	----
Net investment purchase and sale	72.86%17.29M	-177.21%-68.91M	-694.92%-89.61M	-39.69%19.02M	-186.66%-8.32M	-69.74%10M	227.45%89.24M	251.13%15.06M	57.12%31.53M	410.88%9.6M
Cash from discontinued investing activities
Investing cash flow	72.72%17.27M	-176.28%-69.14M	-641.32%-89.65M	-39.93%18.88M	-187.16%-8.37M	-69.74%10M	241.84%90.64M	295.21%16.56M	56.61%31.43M	410.88%9.6M
Financing cash flow
Cash flow from continuing financing activities	0	2,150.49%13.82M	2,003.43%9.19M	0	-24.29%134K	4.49M	-98.84%614K	-83.89%437K	0	-97.13%177K
Net common stock issuance	--0	4,112.00%13.69M	2,713.23%9.14M	--0	--54K	--4.49M	-99.38%325K	-87.50%325K	--0	--0
Proceeds from stock option exercised by employees	----	-55.36%129K	-56.25%49K	--0	----	----	12.02%289K	-1.75%112K	--0	----
Cash from discontinued financing activities
Financing cash flow	--0	2,150.49%13.82M	2,003.43%9.19M	--0	-24.29%134K	--4.49M	-98.84%614K	-83.89%437K	--0	-97.13%177K
Net cash flow
Beginning cash position	-62.15%19.84M	14.88%52.42M	-51.24%26.66M	-49.79%21.62M	-15.03%43.48M	14.88%52.42M	-23.24%45.63M	-22.73%54.67M	-27.65%43.06M	-34.60%51.17M
Current changes in cash	87.78%-1.09M	-579.71%-32.58M	-202.22%-6.82M	-56.65%5.03M	-169.50%-21.86M	-261.10%-8.94M	149.15%6.79M	91.03%-2.26M	3.26%11.61M	56.71%-8.11M
End cash Position	-56.88%18.75M	-62.15%19.84M	-62.15%19.84M	-51.24%26.66M	-49.79%21.62M	-15.03%43.48M	14.88%52.42M	14.88%52.42M	-22.73%54.67M	-27.65%43.06M
Free cash flow	21.56%-18.38M	126.59%22.49M	482.13%73.58M	29.81%-13.98M	23.53%-13.68M	14.81%-23.43M	12.36%-84.57M	0.65%-19.25M	-5.52%-19.92M	17.99%-17.89M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall